FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Fentanyl 300 microgram buccal tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fentanyl 300 microgram buccal tablet Count of base of active ingredient False 1 Inferred relationship Some
    Alcaftadine 2.5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Alcaftadine 2.5 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Risperidone 4 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Risperidone 4 mg orodispersible tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1
    Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment Count of base of active ingredient False 1 Inferred relationship Some
    Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing only mirtazapine in oromucosal dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Tobramycin 3 mg/g eye ointment Count of base of active ingredient False 1 Inferred relationship Some
    Tobramycin 3 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Fentanyl 400 microgram buccal film Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fentanyl 400 microgram buccal film Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only paliperidone in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Hydrocortisone 10 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Hydrocortisone 10 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Memantine hydrochloride 28 mg prolonged-release oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Memantine hydrochloride 28 mg prolonged-release oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Aspirin 81 mg gastro-resistant oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aspirin 81 mg gastro-resistant oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Unoprostone isopropyl 1.5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Unoprostone isopropyl 1.5 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Propamidine isetionate 1.5 mg/g eye ointment Count of base of active ingredient False 1 Inferred relationship Some
    Propamidine isetionate 1.5 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pentobarbital sodium 60 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pentobarbital sodium 60 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Tioconazole 65 mg/g vaginal ointment Count of base of active ingredient False 1 Inferred relationship Some
    Tioconazole 65 mg/g vaginal ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Colestipol hydrochloride 5 g granules for oral suspension sachet Count of base of active ingredient False 1 Inferred relationship Some
    Colestipol hydrochloride 5 g granules for oral suspension sachet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fentanyl 600 microgram/1 each conventional release buccal film (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fentanyl 600 microgram/1 each conventional release buccal film (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 2
    Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only risperidone in oromucosal dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Sulfafurazole 40 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Sulfafurazole 40 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository Has presentation strength denominator value False 1 Inferred relationship Some 1
    Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository Has presentation strength denominator value False 1 Inferred relationship Some 2
    Hydrocortisone acetate 25 mg rectal suppository Count of base of active ingredient False 1 Inferred relationship Some
    Hydrocortisone acetate 25 mg rectal suppository Has presentation strength denominator value False 1 Inferred relationship Some 1
    Magnesium salicylate 580 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Magnesium salicylate 580 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only linaclotide in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 2
    Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Droxidopa 100 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Droxidopa 100 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pentobarbital sodium 120 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pentobarbital sodium 120 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator value False 1 Inferred relationship Some 2
    Estradiol 4.167 microgram/hour prolonged-release vaginal ring Count of base of active ingredient False 1 Inferred relationship Some
    Estradiol 4.167 microgram/hour prolonged-release vaginal ring Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Linaclotide 145 microgram oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Linaclotide 145 microgram oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Ibuprofen 50 mg chewable tablet Count of base of active ingredient False 1 Inferred relationship Some
    Ibuprofen 50 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 173 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start